Home › Funds › Royce & Associates › ZYME
Royce & Associates position in ZYME
ZYMEWORKS INC · Health Care
Latest position (Q1 2026)299.20K sh
Reported value held$7.49M
Portfolio Weight0.07%
First reportedQ1 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 299.20K | $7.49M | New |
Other funds holding ZYME
- BlackRock Inc 4.25M sh · $111.12M · Q2 2026
- Vanguard Group 2.33M sh · $61.32M · Q4 2025
- Morgan Stanley 2.23M sh · $58.33M · Q2 2026
- Citadel Advisors 966.34K sh · $25.26M · Q2 2026
- Fidelity Management & Research (FMR) 702.57K sh · $18.37M · Q2 2026
- Geode Capital Management 692.41K sh · $18.10M · Q2 2026
- Goldman Sachs Group 470.82K sh · $12.31M · Q2 2026
- Arrowstreet Capital 418.50K sh · $10.94M · Q2 2026
- Deutsche Bank AG 397.19K sh · $10.38M · Q2 2026
- Northern Trust Corp 321.07K sh · $8.39M · Q2 2026
- Bank of America Corp 219.07K sh · $5.73M · Q2 2026
- Wells Fargo & Co 217.20K sh · $5.68M · Q2 2026